Top news of the week: 23.02.2022.
Startups
Biotech Is Creating the Jobs of the Future. It’s Time to Give It a Boost.
The booming biotech industry in America is clustered around certain areas for a reason, writes Michelle McMurry-Heath.
Good Day BIO: Gene therapy market will soon follow the science
We recap Day 3 of the CEO & Investor Conference with the outlook on gene therapy and gene editing, and how start-ups can get funding. (784 words, 3 minutes, 55 seconds)
Join Us
Key benefits include: Tap into our unique position in the innovation ecosystem Work directly with Flagship’s highly-experienced team members—a group of widely recognized scientists, ...
Lilly puts $700M into genetic medicine institute
Building on Lilly's acquisition of Prevail Therapeutics, the Boston-based facility will use RNA- and DNA-based technologies to develop new drugs, while also supporting biotech startups in ...
Good Day BIO: New FDA commissioner puts animals on agenda
Beginning the short week with what the newly confirmed FDA Commissioner said about One Health, why CMS “ambushed” efforts to combat pediatric Alzheimer’s, and the start of Rare Disease ...
Dyslexic To Disruptor: Frequency Therapeutics CEO David Lucchino Is Working To Reverse Hearing Loss
David Lucchino, Frequency Therapeutics cofounder and CEO, is a life sciences entrepreneur with nearly two decades of executive leadership experience. Lucchino is dyslexic.
Lilly Plans $700M Genetic Medicine Institute in Boston
Eli Lilly said today it has launched a $700 Institute for Genetic Medicine in Boston’s Fort Point section as part of its strategy to advance RNA- and other nucleic acid-based therapeutics.
Mathers: CMS decision puts future disease cures in crosshairs
If the FDA ultimately approves our drug, it could save the lives of thousands of children with Sanfilippo Syndrome worldwide.